Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Danske Bank A/S $15 Billion Medium-Term Notes Program Update and $1.75 Billion Notes Offering
Davis Polk advised the arranger and dealer in connection with the update of a $15 billion Rule 144A/Regulation S medium-term…
Harmony Gold Mining Equity Private Placement
Davis Polk advised the joint global coordinators of a private placement of new ordinary shares of Harmony Gold Mining…
Davis Polk Advises Netcompany Group A/S on Its Initial Public Offering
Davis Polk advised Netcompany Group A/S on the initial public offering of 20,000,000 existing ordinary shares (excluding any…
Guorui Properties Limited $100 Million High-Yield Notes Offering
Davis Polk advised the sole joint global coordinator, sole lead manager, sole bookrunner and the initial purchaser in…
Central China Real Estate Limited High-Yield Senior Notes Reopening
Davis Polk advised the initial purchasers in connection with the offering of the $86 million principal amount of the 6.875%…
Davis Polk Advises Banco Santander, S.A. on the Establishment of a $20 Billion Commercial Paper Program through its New York Branch
Davis Polk advised Banco Santander, S.A. in connection with the establishment of a $20 billion U.S. commercial paper program…
AVIC International $400 Million Guaranteed Bonds Offering
Davis Polk advised the managers for a Hong Kong law Regulation S only offering by AVIC International Finance &…
Davis Polk Advises The Metropolis of Tokyo on Its $500 Million Bond Offering
Davis Polk advised The Metropolis of Tokyo in connection with its $500 million Rule 144A/Regulation S offering of 3.250%…
Valeant Pharmaceuticals International $4.565 Billion Term Loan Facility and $1.225 Billion Revolving Credit Facility
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) and Valeant Pharmaceuticals International in…
Yara International ASA $1 Billion Notes Offering
Davis Polk advised the lead bookrunning managers and joint global coordinators in connection with a Rule 144A…